Relative Strength Chart Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Real-time Estimate
Cboe BZX
15:13:32 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 548.26 USD | +0.18% |
|
+1.47% | +20.92% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | +0.16% | +1.47% | +20.92% | +40.90% | +174.21% | 139B |  | | |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
